An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
viralvaccines, etc ; bioprocessing; filtration; live vaccines; porosity; Show all 5 Subjects
Abstract:
... Prefilters are widely used to enhance the performance of normal flow filtration steps in bioprocessing; however little is known about the potential benefits of prefiltration in the sterile filtration of viral vaccines and other large particle biotherapeutics. Sterile filtration experiments were performed with a live-attenuated viral vaccine and model nanoparticle suspension, both of which have a s ...
viralvaccines, etc ; encephalitis; fetal death; genotype; live vaccines; public health; viruses; Show all 7 Subjects
Abstract:
... Expansion of genotype I (GI) Japanese encephalitis viruses (JEV) has resulted in the replacement of the dominant genotype III (GIII) viruses, raising serious public health concerns for using GIII virus-derived vaccines to effectively control JEV epidemics. Therefore, this study used swine as the model to estimate the effectiveness of GIII live-attenuated vaccine against GI virus infection by compa ...
Tyler Chozinski; B. Scott Ferguson; William Fisher; Shencheng Ge; Qiang Gong; Hui Kang; John McDermott; Alexander Scott; Wentao Shi; Jeremiah J. Trausch; Thorsten Verch; Matthew Vukovich; Jinpeng Wang; J. Emma Wu; Qin Yang
viralvaccines, etc ; analytical chemistry; electrochemistry; median effective concentration; oligonucleotides; portable equipment; quality control; standard deviation; Show all 8 Subjects
Abstract:
... Global deployment of vaccines poses significant challenges in the distribution and use of the accompanying immunoassays, one of the standard methods for quality control of vaccines, particularly when establishing assays in countries worldwide to support testing/release upon importation. This work describes our effort toward developing an integrated, portable device to carry out affinity assays for ...
viralvaccines, etc ; RNA; Severe acute respiratory syndrome coronavirus 2; coculture; genome; infection; live vaccines; mutation rate; natural selection; Show all 9 Subjects
Abstract:
... The best and most effective way to combat pandemics is to use effective vaccines and live attenuated vaccines are among the most effective vaccines. However, one of the major problems is the length of time it takes to get the attenuated vaccines. Today, the CRISPR toolkit (Clustered Regularly Inerspaced Short Palindromic Repeats) has made it possible to make changes with high efficiency and speed. ...
Libia Milena Hernandez; K. Sumathy; Sushant Sahastrabuddhe; Jean-Louis Excler; Sonali Kochhar; Emily R. Smith; Marc Gurwith; Robert T. Chen; Benefit-Risk Assessment of VAccines by TechnolOgy Working Group (BRAVATO, ex-V3SWG)
... Inactivated viral vaccines have long been used in humans for diseases of global health threat (e.g., poliomyelitis and pandemic and seasonal influenza) and the technology of inactivation has more recently been used for emerging diseases such as West Nile, Chikungunya, Ross River, SARS and especially for COVID-19. The Brighton Collaboration Benefit-Risk Assessment of VAccines by TechnolOgy (BRAVATO ...
viralvaccines, etc ; Infectious hematopoietic necrosis virus; Oncorhynchus mykiss; Yersinia ruckeri; antibodies; blood serum; fish; juveniles; live vaccines; mortality; mouth; necrosis; nose; spleen; vaccination; Show all 15 Subjects
Abstract:
... Previous research demonstrated that bacterial and viral vaccines delivered via the nasal route in rainbow trout (Oncorhynchus mykiss) at 7 and 28 days post-vaccination are highly protective (>95% protection). Long-term protection following nasal vaccination in teleosts has not been evaluated. The goal of this study was to assess efficacy and immune responses at 6 months (mo) post-vaccination (mpv) ...
viralvaccines, etc ; COVID-19 infection; Severe acute respiratory syndrome coronavirus 2; antibodies; antibody formation; blood; blood pressure; health services; hypertension; questionnaires; retrospective studies; vaccination; viruses; Show all 13 Subjects
Abstract:
... Several types of vaccines have been developed to prevent the coronavirus disease 2019 (COVID-19). It is important to understand whether demographic and clinical variables affect the effectiveness of various types of vaccines. This study analysed the association between demographic/clinical factors, antibody response and vaccine effectiveness in healthcare workers vaccinated with inactivated virus. ...
Jessie Payne; James Cronin; Manjit Haer; Jason Krouse; William Prosperi; Katherine Drolet-Vives; Matthew Lieve; Michael Soika; Matthew Balmer; Marina Kirkitadze
viralvaccines, etc ; biotechnology; filtration; multivariate analysis; surfactants; Show all 5 Subjects
Abstract:
... The goal of this study is to examine the suitability of in-line infrared measurements to monitor, in real-time, surfactant concentration in the viral vaccine drug substance during a 50KDa tangential flow filtration (TFF) process.A ReactIR™ 702L instrument was used to gather spectra of process off-line samples and reference materials to assess the feasibility of monitoring surfactant concentration ...
viralvaccines, etc ; Hepatitis C virus; epigenetics; hepatitis C; immune response; serology; transcriptomics; vaccine development; Show all 8 Subjects
Abstract:
... Over the past decade, tremendous progress has been made in systems biology-based approaches to studying immunity to viral infections and responses to vaccines. These approaches that integrate multiple facets of the immune response, including transcriptomics, serology and immune functions, are now being applied to understand correlates of protective immunity against hepatitis C virus (HCV) infectio ...
viralvaccines, etc ; adhesion; analytical chemistry; gene therapy; hydrophobic interaction chromatography; hydrophobicity; live vaccines; porosity; thermoplastics; Show all 9 Subjects
Abstract:
... Nanoparticle hydrophobicity is a key factor controlling the stability, adhesion, and transport of nanoparticle suspensions. Although a number of approaches have been presented for evaluating nanoparticle hydrophobicity, these methods are difficult to apply to larger nanoparticles and viruses (>100 nm in size) that are of increasing importance in drug delivery and gene therapy. This study investiga ...
... Herpes simplex virus (HSV) prevention is a global health priority but, despite decades of research, there is no effective vaccine. Prior efforts focused on generating glycoprotein D (gD) neutralizing antibodies, but clinical trial outcomes were disappointing. The deletion of gD yields a single-cycle candidate vaccine (∆gD-2) that elicits high titer polyantigenic non-gD antibodies that exhibit litt ...
... Canine distemper virus (CDV) can infect a variety of predators, such as Canidae, Mustelidae and Procyonidae family and cause high morbidity and mortality. Genetic/antigenic heterogeneity has been observed among various CDV strains, notably in the haemagglutinin (H) gene. Based on sequence analysis of the H gene, wild-type CDV strains can be divided into distinct genotypes. We used Vero/SLAM cells ...
... Newborn calves experience oxidative stress throughout the first month of their life, which is known to decrease lymphocyte functions relevant to vaccine responsiveness. Thus, this study aimed to determine the extent to which parenteral antioxidant supplementation given at birth improves the response to an intranasal viral vaccine in the first month of life of newborn dairy calves. For this, 21 cal ...
Ana T. Duggan; Jennifer Klunk; Ashleigh F. Porter; Anna N. Dhody; Robert Hicks; Geoffrey L. Smith; Margaret Humphreys; Andrea M. McCollum; Whitni B. Davidson; Kimberly Wilkins; Yu Li; Amanda Burke; Hanna Polasky; Lowell Flanders; Debi Poinar; Amogelang R. Raphenya; Tammy T. Y. Lau; Brian Alcock; Andrew G. McArthur; G. Brian Golding; Edward C. Holmes; Hendrik N. Poinar
viralvaccines, etc ; Poxviridae; genetic variation; genome; smallpox; vaccination; Show all 6 Subjects
Abstract:
... Vaccination has transformed public health, most notably including the eradication of smallpox. Despite its profound historical importance, little is known of the origins and diversity of the viruses used in smallpox vaccination. Prior to the twentieth century, the method, source and origin of smallpox vaccinations remained unstandardised and opaque. We reconstruct and analyse viral vaccine genomes ...
Chang Liu; Helen M. Ginn; Wanwisa Dejnirattisai; Piyada Supasa; Beibei Wang; Aekkachai Tuekprakhon; Rungtiwa Nutalai; Daming Zhou; Alexander J. Mentzer; Yuguang Zhao; Helen M.E. Duyvesteyn; César López-Camacho; Jose Slon-Campos; Thomas S. Walter; Donal Skelly; Sile Ann Johnson; Thomas G. Ritter; Chris Mason; Sue Ann Costa Clemens; Felipe Gomes Naveca; Valdinete Nascimento; Fernanda Nascimento; Cristiano Fernandes da Costa; Paola Cristina Resende; Alex Pauvolid-Correa; Marilda M. Siqueira; Christina Dold; Nigel Temperton; Tao Dong; Andrew J. Pollard; Julian C. Knight; Derrick Crook; Teresa Lambe; Elizabeth Clutterbuck; Sagida Bibi; Amy Flaxman; Mustapha Bittaye; Sandra Belij-Rammerstorfer; Sarah C. Gilbert; Tariq Malik; Miles W. Carroll; Paul Klenerman; Eleanor Barnes; Susanna J. Dunachie; Vicky Baillie; Natali Serafin; Zanele Ditse; Kelly Da Silva; Neil G. Paterson; Mark A. Williams; David R. Hall; Shabir Madhi; Marta C. Nunes; Philip Goulder; Elizabeth E. Fry; Juthathip Mongkolsapaya; Jingshan Ren; David I. Stuart; Gavin R. Screaton
viralvaccines, etc ; COVID-19 infection; Severe acute respiratory syndrome coronavirus 2; antigenic variation; antiserum; monoclonal antibodies; neutralizing antibodies; vaccination; viral antibodies; viral antigens; Show all 10 Subjects
Abstract:
... Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has undergone progressive change, with variants conferring advantage rapidly becoming dominant lineages, e.g., B.1.617. With apparent increased transmissibility, variant B.1.617.2 has contributed to the current wave of infection ravaging the Indian subcontinent and has been designated a variant of concern in the United Kingdom. Here we s ...
Shylo R. Johnson; Dennis Slate; Kathleen M. Nelson; Amy J. Davis; Samual A. Mills; John T. Forbes; Kurt C. VerCauteren; Amy T. Gilbert; Richard B. Chipman
viralvaccines, etc ; Mephitis mephitis; Procyon lotor; Rabies lyssavirus; baits; disease control; edible vaccines; neutralizing antibodies; oral vaccination; rabies; seroprevalence; skunks; wildlife; West Virginia; Show all 14 Subjects
Abstract:
... Since the 1990s, oral rabies vaccination (ORV) has been used successfully to halt the westward spread of the raccoon rabies virus (RV) variant from the eastern continental USA. Elimination of raccoon RV from the eastern USA has proven challenging across targeted raccoon (Procyon lotor) and striped skunk (Mephitis mephitis) populations impacted by raccoon RV. Field trial evaluations of the Ontario ...
... Astragaloside VII (AST-VII), a major cycloartane saponin isolated from Turkish Astragalus species, turned out to be one of the most active metabolites demonstrating Th1/Th2 balanced immune response. As Quillaja saponins are extensively used in adjuvant systems, this study made an attempt to improve AST-VII based adjuvant systems by using different immunostimulatory/delivery agents (monophosphoryll ...
viralvaccines, etc ; Angus; Nellore; animal performance; beef cattle; body weight; bovine viral diarrhea; crossbreds; dry matter intake; inactivated vaccines; intranasal administration; live vaccines; steers; temperament; vaccination; Show all 15 Subjects
Abstract:
... This study examined the effects of multivalent respiratory vaccine treatment (VT) and animal temperament classification on feeding behavior traits, feed intake and animal performance in response to a bovine viral diarrhea virus (BVDV) challenge. Nellore–Angus crossbred steers (n = 360; initial body weight (BW) 330 ± 48 kg) were assigned to one of three vaccine treatments: non-vaccinated (NON), mod ...
viralvaccines, etc ; Haemophilus; asymmetry; formaldehyde; hepatitis B; humans; liquids; octoxynol; purification methods; Show all 9 Subjects
Abstract:
... Many of the inactivated viral vaccines for human and animal use are manufactured using formaldehyde as an inactivating agent. Apart from formaldehyde, Triton X-100 is also one of the chemicals commonly used in viral vaccine manufacturing. Triton X-100 is typically used to extract the cell-associated viruses and / or components during manufacturing process. The concentration of formaldehyde and Tri ...
viralvaccines, etc ; gel electrophoresis; gels; glycoproteins; influenza; pH; temperature; vaccine development; virion; wavelengths; Show all 10 Subjects
Abstract:
... Vaccines against infectious diseases are urgently needed. Therefore, modern analytical method development should be as efficient as possible to speed up vaccine development. The objectives of the study were to identify critical method parameters (CMPs) and to establish a set of steps to efficiently develop and validate a CE‐SDS method for vaccine protein analysis based on a commercially available ...